18 0 2 0 2 B-lower_bound
years 3 8 3 8 I-lower_bound
of 9 11 9 11 O
age 12 15 12 15 B-age
or 16 18 16 18 O
greater 19 26 19 26 O

Active 0 6 27 33 B-chronic_disease
coronary 7 15 34 42 I-chronic_disease
artery 16 22 43 49 I-chronic_disease
disease 23 30 50 57 I-chronic_disease

Active 0 6 58 64 O
or 7 9 65 67 O
clinically 10 20 68 78 O
significant 21 32 79 90 O
cardiac 33 40 91 98 B-chronic_disease
disease 41 48 99 106 I-chronic_disease

Alanine 0 7 107 114 B-clinical_variable
aminotransferase 8 24 115 131 I-clinical_variable
( 25 26 132 133 I-clinical_variable
ALT 26 29 133 136 I-clinical_variable
) 29 30 136 137 I-clinical_variable
and 31 34 138 141 O
aspartate 35 44 142 151 B-clinical_variable
aminotransferase 45 61 152 168 I-clinical_variable
( 62 63 169 170 I-clinical_variable
AST 63 66 170 173 I-clinical_variable
) 66 67 173 174 I-clinical_variable
≤ 68 69 175 176 O
2.5 70 73 177 180 B-upper_bound
x 74 75 181 182 I-upper_bound
ULN 76 79 183 186 I-upper_bound
( 80 81 187 188 O
≤ 81 82 188 189 O
5 83 84 190 191 O
x 85 86 192 193 O
ULN 87 90 194 197 O
for 91 94 198 201 O
subjects 95 103 202 210 O
with 104 108 211 215 O
liver 109 114 216 221 O
involvement 115 126 222 233 O
of 127 129 234 236 O
their 130 135 237 242 O
cancer 136 142 243 249 B-cancer
) 142 143 249 250 O

Alkaline 0 8 251 259 B-clinical_variable
phosphatase 9 20 260 271 I-clinical_variable
limit 21 26 272 277 I-clinical_variable
≤ 27 28 278 279 O
2.5 29 32 280 283 B-upper_bound
x 33 34 284 285 I-upper_bound
ULN 35 38 286 289 I-upper_bound
( 39 40 290 291 O
≤ 40 41 291 292 O
5 42 43 293 294 O
x 44 45 295 296 O
ULN 46 49 297 300 O
for 50 53 301 304 O
subjects 54 62 305 313 O
with 63 67 314 318 O
liver 68 73 319 324 O
or 74 76 325 327 O
bone 77 81 328 332 O
involvement 82 93 333 344 O
of 94 96 345 347 O
their 97 102 348 353 O
cancer 103 109 354 360 B-cancer
) 109 110 360 361 O

Cardiac 0 7 362 369 B-chronic_disease
arrhythmias 8 19 370 381 I-chronic_disease
requiring 20 29 382 391 O
anti 30 34 392 396 B-treatment
- 34 35 396 397 I-treatment
arrhythmic 35 45 397 407 I-treatment
therapy 46 53 408 415 I-treatment
other 54 59 416 421 O
than 60 64 422 426 O
beta 65 69 427 431 B-treatment
blockers 70 78 432 440 I-treatment
or 79 81 441 443 O
digoxin 82 89 444 451 B-treatment

Congestive 0 10 452 462 B-chronic_disease
heart 11 16 463 468 I-chronic_disease
failure 17 24 469 476 I-chronic_disease

Diagnosis 0 9 477 486 O
of 10 12 487 489 O
relapsed 13 21 490 498 B-cancer
/ 21 22 498 499 I-cancer
refractory 22 32 499 509 I-cancer
advanced 33 41 510 518 I-cancer
malignancies 42 54 519 531 I-cancer

History 0 7 532 539 O
of 8 10 540 542 O
organ 11 16 543 548 B-treatment
allograft 17 26 549 558 I-treatment
( 27 28 559 560 O
including 28 37 560 569 O
corneal 38 45 570 577 B-treatment
transplant 46 56 578 588 I-treatment
) 56 57 588 589 O

Known 0 5 590 595 O
history 6 13 596 603 O
of 14 16 604 606 O
human 17 22 607 612 B-chronic_disease
immunodeficiency 23 39 613 629 I-chronic_disease
virus 40 45 630 635 I-chronic_disease
( 46 47 636 637 I-chronic_disease
HIV 47 50 637 640 I-chronic_disease
) 50 51 640 641 I-chronic_disease
infection 52 61 642 651 I-chronic_disease
or 62 64 652 654 O
current 65 72 655 662 O
chronic 73 80 663 670 O
or 81 83 671 673 O
active 84 90 674 680 O
hepatitis 91 100 681 690 B-chronic_disease
B 101 102 691 692 I-chronic_disease
or 103 105 693 695 I-chronic_disease
C 106 107 696 697 I-chronic_disease
infection 108 117 698 707 I-chronic_disease
requiring 118 127 708 717 O
treatment 128 137 718 727 B-treatment
with 138 142 728 732 I-treatment
antiviral 143 152 733 742 I-treatment
therapy 153 160 743 750 I-treatment

Known 0 5 751 756 O
or 6 8 757 759 O
suspected 9 18 760 769 O
allergy 19 26 770 777 O
or 27 29 778 780 O
hypersensitivity 30 46 781 797 O
to 47 49 798 800 O
any 50 53 801 804 O
of 54 56 805 807 O
the 57 60 808 811 O
study 61 66 812 817 B-allergy_name
drugs 67 72 818 823 I-allergy_name
, 72 73 823 824 O
study 74 79 825 830 B-allergy_name
drug 80 84 831 835 I-allergy_name
classes 85 92 836 843 I-allergy_name
, 92 93 843 844 O
or 94 96 845 847 O
excipients 97 107 848 858 O
of 108 110 859 861 O
the 111 114 862 865 O
formulations 115 127 866 878 O
given 128 133 879 884 O
during 134 140 885 891 O
the 141 144 892 895 O
course 145 151 896 902 O
of 152 154 903 905 O
this 155 159 906 910 O
trial 160 165 911 916 O

Major 0 5 917 922 B-treatment
surgical 6 14 923 931 I-treatment
procedure 15 24 932 941 I-treatment
or 25 27 942 944 O
significant 28 39 945 956 B-treatment
traumatic 40 49 957 966 I-treatment
injury 50 56 967 973 I-treatment
within 57 63 974 980 O
28 64 66 981 983 B-upper_bound
days 67 71 984 988 I-upper_bound
before 72 78 989 995 O
start 79 84 996 1001 O
of 85 87 1002 1004 O
study 88 93 1005 1010 B-treatment
medication 94 104 1011 1021 I-treatment

New 0 3 1022 1025 B-clinical_variable
York 4 8 1026 1030 I-clinical_variable
Heart 9 14 1031 1036 I-clinical_variable
Association 15 26 1037 1048 I-clinical_variable
( 27 28 1049 1050 I-clinical_variable
NYHA 28 32 1050 1054 I-clinical_variable
) 32 33 1054 1055 I-clinical_variable
> 34 35 1056 1057 O
Class 36 41 1058 1063 B-lower_bound
II 42 44 1064 1066 I-lower_bound

Persistent 0 10 1067 1077 B-clinical_variable
proteinuria 11 22 1078 1089 I-clinical_variable
≥ 23 24 1090 1091 O
Grade 25 30 1092 1097 B-lower_bound
3 31 32 1098 1099 I-lower_bound
NCI 33 36 1100 1103 O
- 36 37 1103 1104 O
CTCAE 37 42 1104 1109 O
v4.0 43 47 1110 1114 O
( 48 49 1115 1116 O
> 49 50 1116 1117 O
3.5 51 54 1118 1121 B-lower_bound
g/24 55 59 1122 1126 I-lower_bound
hrs 60 63 1127 1130 I-lower_bound
, 63 64 1130 1131 O
measured 65 73 1132 1140 O
by 74 76 1141 1143 O
urine 77 82 1144 1149 O
protein 83 90 1150 1157 O
: 90 91 1157 1158 O
creatinine 92 102 1159 1169 O
ratio 103 108 1170 1175 O
on 109 111 1176 1178 O
a 112 113 1179 1180 O
random 114 120 1181 1187 O
urine 121 126 1188 1193 O
sample 127 133 1194 1200 O
) 133 134 1200 1201 O

Post 0 4 1202 1206 O
- 4 5 1206 1207 O
menopausal 5 15 1207 1217 O
women 16 21 1218 1223 B-gender
( 22 23 1224 1225 O
defined 23 30 1225 1232 O
as 31 33 1233 1235 O
no 34 36 1236 1238 O
menses 37 43 1239 1245 O
for 44 47 1246 1249 O
at 48 50 1250 1252 O
least 51 56 1253 1258 O
1 57 58 1259 1260 B-lower_bound
year 59 63 1261 1265 I-lower_bound
) 63 64 1265 1266 O
and 65 68 1267 1270 O
surgically 69 79 1271 1281 O
sterilized 80 90 1282 1292 O
women 91 96 1293 1298 O
are 97 100 1299 1302 O
not 101 104 1303 1306 O
required 105 113 1307 1315 O
to 114 116 1316 1318 O
undergo 117 124 1319 1326 O
a 125 126 1327 1328 O
pregnancy 127 136 1329 1338 B-pregnancy
test 137 141 1339 1343 O

Presence 0 8 1344 1352 O
of 9 11 1353 1355 O
unresolved 12 22 1356 1366 O
toxicities 23 33 1367 1377 O
from 34 38 1378 1382 O
prior 39 44 1383 1388 O
anticancer 45 55 1389 1399 B-treatment
therapy 56 63 1400 1407 I-treatment
, 63 64 1407 1408 O
defined 65 72 1409 1416 O
as 73 75 1417 1419 O
having 76 82 1420 1426 O
not 83 86 1427 1430 O
resolved 87 95 1431 1439 O
to 96 98 1440 1442 O
NCI 99 102 1443 1446 O
CTCAE 103 108 1447 1452 O
v4.03 109 114 1453 1458 O
grade 115 120 1459 1464 O
0 121 122 1465 1466 O
or 123 125 1467 1469 O
1 126 127 1470 1471 O
with 128 132 1472 1476 O
the 133 136 1477 1480 O
exception 137 146 1481 1490 O
of 147 149 1491 1493 O
alopecia 150 158 1494 1502 B-chronic_disease

Previous 0 8 1503 1511 O
assignment 9 19 1512 1522 O
to 20 22 1523 1525 O
treatment 23 32 1526 1535 B-treatment
during 33 39 1536 1542 O
this 40 44 1543 1547 O
study 45 50 1548 1553 O

Previously 0 10 1554 1564 O
untreated 11 20 1565 1574 O
or 21 23 1575 1577 O
concurrent 24 34 1578 1588 O
cancer 35 41 1589 1595 B-cancer
that 42 46 1596 1600 O
is 47 49 1601 1603 O
distinct 50 58 1604 1612 O
in 59 61 1613 1615 O
primary 62 69 1616 1623 O
site 70 74 1624 1628 O
or 75 77 1629 1631 O
histology 78 87 1632 1641 O
except 88 94 1642 1648 O
cervical 95 103 1649 1657 B-cancer
cancer 104 110 1658 1664 I-cancer
in 111 113 1665 1667 I-cancer
- 113 114 1667 1668 I-cancer
situ 114 118 1668 1672 I-cancer

Seizure 0 7 1673 1680 B-chronic_disease
disorder 8 16 1681 1689 I-chronic_disease
requiring 17 26 1690 1699 O
medication 27 37 1700 1710 O

Serum 0 5 1711 1716 B-clinical_variable
creatinine 6 16 1717 1727 I-clinical_variable
≤ 17 18 1728 1729 O
1.5 19 22 1730 1733 B-upper_bound
x 23 24 1734 1735 I-upper_bound
the 25 28 1736 1739 I-upper_bound
ULN 29 32 1740 1743 I-upper_bound

Subjects 0 8 1744 1752 O
surviving 9 18 1753 1762 O
a 19 20 1763 1764 O
cancer 21 27 1765 1771 B-cancer
that 28 32 1772 1776 O
was 33 36 1777 1780 O
curatively 37 47 1781 1791 O
treated 48 55 1792 1799 O
and 56 59 1800 1803 O
without 60 67 1804 1811 O
evidence 68 76 1812 1820 O
of 77 79 1821 1823 O
disease 80 87 1824 1831 O
for 88 91 1832 1835 O
more 92 96 1836 1840 O
than 97 101 1841 1845 O
3 102 103 1846 1847 B-lower_bound
years 104 109 1848 1853 I-lower_bound
before 110 116 1854 1860 O
registration 117 129 1861 1873 O
are 130 133 1874 1877 O
allowed 134 141 1878 1885 O

Subjects 0 8 1886 1894 O
who 9 12 1895 1898 O
are 13 16 1899 1902 O
prophylactically 17 33 1903 1919 O
treated 34 41 1920 1927 O
with 42 46 1928 1932 O
an 47 49 1933 1935 O
agent 50 55 1936 1941 O
such 56 60 1942 1946 O
as 61 63 1947 1949 O
warfarin 64 72 1950 1958 B-treatment
or 73 75 1959 1961 O
heparin 76 83 1962 1969 B-treatment
will 84 88 1970 1974 O
be 89 91 1975 1977 O
allowed 92 99 1978 1985 O
to 100 102 1986 1988 O
participate 103 114 1989 2000 O
provided 115 123 2001 2009 O
that 124 128 2010 2014 O
no 129 131 2015 2017 O
prior 132 137 2018 2023 O
evidence 138 146 2024 2032 O
of 147 149 2033 2035 O
underlying 150 160 2036 2046 O
abnormality 161 172 2047 2058 O
in 173 175 2059 2061 O
coagulation 176 187 2062 2073 O
parameters 188 198 2074 2084 O
exists 199 205 2085 2091 O

Thrombotic 0 10 2092 2102 B-chronic_disease
, 10 11 2102 2103 I-chronic_disease
embolic 12 19 2104 2111 I-chronic_disease
, 19 20 2111 2112 I-chronic_disease
venous 21 27 2113 2119 I-chronic_disease
or 28 30 2120 2122 I-chronic_disease
arterial 31 39 2123 2131 I-chronic_disease
events 40 46 2132 2138 I-chronic_disease

Total 0 5 2139 2144 B-clinical_variable
bilirubin 6 15 2145 2154 I-clinical_variable
≤ 16 17 2155 2156 O
1.5 18 21 2157 2160 B-upper_bound
x 22 23 2161 2162 I-upper_bound
the 24 27 2163 2166 I-upper_bound
upper 28 33 2167 2172 I-upper_bound
limits 34 40 2173 2179 I-upper_bound
of 41 43 2180 2182 I-upper_bound
normal 44 50 2183 2189 I-upper_bound
( 51 52 2190 2191 I-upper_bound
ULN 52 55 2191 2194 I-upper_bound
) 55 56 2194 2195 I-upper_bound
except 57 63 2196 2202 O
for 64 67 2203 2206 O
patients 68 76 2207 2215 O
with 77 81 2216 2220 O
Gilbert 82 89 2221 2228 B-chronic_disease
's 89 91 2228 2230 I-chronic_disease
disease 92 99 2231 2238 I-chronic_disease

Uncontrolled 0 12 2239 2251 O
inter 13 18 2252 2257 B-chronic_disease
- 18 19 2257 2258 I-chronic_disease
current 19 26 2258 2265 I-chronic_disease
illness 27 34 2266 2273 I-chronic_disease
including 35 44 2274 2283 O
, 44 45 2283 2284 O
but 46 49 2285 2288 O
not 50 53 2289 2292 O
limited 54 61 2293 2300 O
to 62 64 2301 2303 O
, 64 65 2303 2304 O
ongoing 66 73 2305 2312 O
or 74 76 2313 2315 O
active 77 83 2316 2322 B-chronic_disease
infection 84 93 2323 2332 I-chronic_disease
, 93 94 2332 2333 O
symptomatic 95 106 2334 2345 O
congestive 107 117 2346 2356 B-chronic_disease
heart 118 123 2357 2362 I-chronic_disease
failure 124 131 2363 2370 I-chronic_disease
, 131 132 2370 2371 O
uncontrolled 133 145 2372 2384 B-chronic_disease
hypertension 146 158 2385 2397 I-chronic_disease
, 158 159 2397 2398 O
unstable 160 168 2399 2407 B-chronic_disease
angina 169 175 2408 2414 I-chronic_disease
pectoris 176 184 2415 2423 I-chronic_disease
, 184 185 2423 2424 O
uncontrolled 186 198 2425 2437 O
cardiac 199 206 2438 2445 B-chronic_disease
arrhythmia 207 217 2446 2456 I-chronic_disease
, 217 218 2456 2457 O
or 219 221 2458 2460 O
psychiatric 222 233 2461 2472 B-chronic_disease
illness 234 241 2473 2480 I-chronic_disease
/ 241 242 2480 2481 I-chronic_disease
social 242 248 2481 2487 I-chronic_disease
situations 249 259 2488 2498 I-chronic_disease
that 260 264 2499 2503 O
would 265 270 2504 2509 O
limit 271 276 2510 2515 O
compliance 277 287 2516 2526 O
with 288 292 2527 2531 O
study 293 298 2532 2537 O
requirements 299 311 2538 2550 O

Unstable 0 8 2551 2559 B-chronic_disease
angina 9 15 2560 2566 I-chronic_disease
( 16 17 2567 2568 O
anginal 17 24 2568 2575 O
symptoms 25 33 2576 2584 O
at 34 36 2585 2587 O
rest 37 41 2588 2592 O
) 41 42 2592 2593 O

Women 0 5 2594 2599 B-gender
of 6 8 2600 2602 O
childbearing 9 21 2603 2615 O
potential 22 31 2616 2625 O
must 32 36 2626 2630 B-pregnancy
have 37 41 2631 2635 I-pregnancy
a 42 43 2636 2637 I-pregnancy
negative 44 52 2638 2646 I-pregnancy
serum 53 58 2647 2652 I-pregnancy
pregnancy 59 68 2653 2662 I-pregnancy
test 69 73 2663 2667 O
performed 74 83 2668 2677 O
within 84 90 2678 2684 O
7 91 92 2685 2686 B-upper_bound
days 93 97 2687 2691 I-upper_bound
prior 98 103 2692 2697 I-upper_bound
to 104 106 2698 2700 O
the 107 110 2701 2704 O
start 111 116 2705 2710 O
of 117 119 2711 2713 O
study 120 125 2714 2719 O
drug 126 130 2720 2724 O

Women 0 5 2725 2730 B-gender
who 6 9 2731 2734 O
are 10 13 2735 2738 B-pregnancy
pregnant 14 22 2739 2747 I-pregnancy
or 23 25 2748 2750 O
breast 26 32 2751 2757 O
- 32 33 2757 2758 O
feeding 33 40 2758 2765 O
, 40 41 2765 2766 O
or 42 44 2767 2769 O
intend 45 51 2770 2776 B-pregnancy
to 52 54 2777 2779 I-pregnancy
become 55 61 2780 2786 I-pregnancy
pregnant 62 70 2787 2795 I-pregnancy
during 71 77 2796 2802 O
the 78 81 2803 2806 O
study 82 87 2807 2812 O

curatively 0 10 2813 2823 O
treated 11 18 2824 2831 O
non 19 22 2832 2835 B-cancer
- 22 23 2835 2836 I-cancer
melanoma 23 31 2836 2844 I-cancer
skin 32 36 2845 2849 I-cancer
carcinoma 37 46 2850 2859 I-cancer

myelodysplastic 0 15 2860 2875 B-cancer
syndrome 16 24 2876 2884 I-cancer
that 25 29 2885 2889 O
have 30 34 2890 2894 O
failed 35 41 2895 2901 O
hypomethylating 42 57 2902 2917 O
agents 58 64 2918 2924 O

myelofibrosis 0 13 2925 2938 B-cancer
that 14 18 2939 2943 O
have 19 23 2944 2948 O
failed 24 30 2949 2955 O
ruxolitinib 31 42 2956 2967 B-treatment
or 43 45 2968 2970 O
are 46 49 2971 2974 O
ineligible 50 60 2975 2985 O
for 61 64 2986 2989 O
this 65 69 2990 2994 O
therapy 70 77 2995 3002 B-treatment

myocardial 0 10 3003 3013 B-chronic_disease
infarction 11 21 3014 3024 I-chronic_disease
within 22 28 3025 3031 O
6 29 30 3032 3033 B-upper_bound
months 31 37 3034 3040 I-upper_bound
before 38 44 3041 3047 O
randomization 45 58 3048 3061 O

new 0 3 3062 3065 O
- 3 4 3065 3066 O
onset 4 9 3066 3071 O
angina 10 16 3072 3078 B-chronic_disease
within 17 23 3079 3085 O
3 24 25 3086 3087 B-upper_bound
months 26 32 3088 3094 I-upper_bound
before 33 39 3095 3101 O
randomization 40 53 3102 3115 O

non 0 3 3116 3119 B-chronic_disease
- 3 4 3119 3120 I-chronic_disease
healing 4 11 3120 3127 I-chronic_disease
ulcer 12 17 3128 3133 I-chronic_disease
or 18 20 3134 3136 O
bone 21 25 3137 3141 O
fracture 26 34 3142 3150 O

noninvasive 0 11 3151 3162 B-chronic_disease
aerodigestive 12 25 3163 3176 I-chronic_disease
neoplasms 26 35 3177 3186 I-chronic_disease

relapsed 0 8 3187 3195 O
refractory 9 19 3196 3206 O
refractory 20 30 3207 3217 B-cancer
acute 31 36 3218 3223 I-cancer
myeloid 37 44 3224 3231 I-cancer
leukemia 45 53 3232 3240 I-cancer
that 54 58 3241 3245 O
have 59 63 3246 3250 O
failed 64 70 3251 3257 O
one 71 74 3258 3261 O
line 75 79 3262 3266 O
of 80 82 3267 3269 O
prior 83 88 3270 3275 B-treatment
therapy 89 96 3276 3283 I-treatment

superficial 0 11 3284 3295 B-cancer
bladder 12 19 3296 3303 I-cancer
tumor 20 25 3304 3309 I-cancer

